Duchenne muscular dystrophy (DMD) is a neuromuscular disease causing progressive skeletal muscle weakness and fatigue. The research team led by Associate Professor Hidetoshi Sakurai (Department of Clinical Application), Researcher Nana Takenaka-Ninagawa, and graduate student Clémence Kiho Yoshioka recently demonstrated the beneficial effects of cell therapy-mediated dystrophin supplementation by reducing muscle fatigue and enhancing mitochondrial activity.
Preventing skeletal muscle fatigue in Duchenne muscular dystrophy through cell therapy
